Conversely, in large, controlled trials of anti-VEGF drugs in diabetic macular oedema and retinal vein occlusion, macular atrophy attributable to these drugs has not been detected [76,77,78]. The gene discussed is VEGFA; the disease is retinal vein occlusion.